For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Fycompa 4 mg Daily | Fycompa: Fycompa 4 mg daily | 0 | None | 0 | 1 | 0 | 1 | View |
| Fycompa 4 mg Daily With a Boost to 6 mg Daily | Fycompa with a boost: Fycompa 4 mg daily with a boost to 6 mg daily a week before the start of your menstruation cycle until Day 4 of your cycle. | 0 | None | 0 | 3 | 1 | 3 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Feeling off | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |